- TheStreet.com•22 minutes ago
Boston Scientific (BSX) stock is advancing this morning after the company posted better-than-expected fiscal 2016 second quarter revenue before today's opening bell.
- American City Business Journals•2 hours ago
Boston Scientific Corp. announced better-than-expected sales for the second quarter and said it expects full-year revenue to grow as much as 12 percent. The Boston Business Journal reports that Boston Scientific raised its full-year outlook for the second time in months, to a range of $8.27 billion to $8.37 billion . The Boston Business Journal has more on that deal .
|Bid||23.96 x 1800|
|Ask||23.97 x 5000|
|52wk Range||14.18 - 24.79|
|Day's Range||23.83 - 24.79|
|Avg Vol (3m)||10,943,963|
As of 10:32 AM EDT. NYSE Real Time Price. Market open.